These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10786812)
1. Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients. Fernández-Figueras MT; Puig L; Fernández-Vasalo A; Esquius M; Montero MA; Ariza A Mod Pathol; 2000 Apr; 13(4):438-45. PubMed ID: 10786812 [TBL] [Abstract][Full Text] [Related]
2. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma. Rosado FG; Itani DM; Coffin CM; Cates JM Arch Pathol Lab Med; 2012 Mar; 136(3):301-4. PubMed ID: 22372906 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma. Varricchio F; Husain SR; Leland P; Gill P; Puri RK Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of c-Met in Kaposi's sarcoma according to progression stage and HIV infection status. Puig L; Fernández-Figueras MT; Penín RM; Esquius M; Alomar A; Ariza A J Cutan Pathol; 1999 May; 26(5):227-31. PubMed ID: 10408347 [TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597 [TBL] [Abstract][Full Text] [Related]
6. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions. Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil. Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742 [TBL] [Abstract][Full Text] [Related]
8. NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma. Goodier MR; Mela CM; Steel A; Gazzard B; Bower M; Gotch F J Virol; 2007 Jan; 81(1):430-3. PubMed ID: 17035308 [TBL] [Abstract][Full Text] [Related]
10. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020 [TBL] [Abstract][Full Text] [Related]
11. Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Morris CB; Gendelman R; Marrogi AJ; Lu M; Lockyer JM; Alperin-Lea W; Ensoli B Am J Pathol; 1996 Apr; 148(4):1055-63. PubMed ID: 8644847 [TBL] [Abstract][Full Text] [Related]
12. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955 [TBL] [Abstract][Full Text] [Related]
13. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522 [TBL] [Abstract][Full Text] [Related]
14. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement. Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213 [TBL] [Abstract][Full Text] [Related]
15. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. Pak F; Pyakural P; Kokhaei P; Kaaya E; Pourfathollah AA; Selivanova G; Biberfeld P J Cutan Pathol; 2005 Jan; 32(1):21-7. PubMed ID: 15660651 [TBL] [Abstract][Full Text] [Related]
16. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu. Dezube BJ Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and p53 immunoprofile in Kaposi's sarcoma. Pillay P; Chetty R; Reddy R Pathol Oncol Res; 1999; 5(1):17-20. PubMed ID: 10079372 [TBL] [Abstract][Full Text] [Related]
18. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319 [TBL] [Abstract][Full Text] [Related]
20. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U; J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]